AI-generated summary
The authors studied photobiomodulation (PBM) with and without radiation in A431 cells and in mouse xenograft tumors. They report that PBM alone did not increase cell proliferation, but it raised the G2/M cell fraction and enhanced the radiation effect in cell assays, and the PBM-plus-radiation group had longer median survival than radiation alone. The study is an early preclinical report.
- Who or what was studied
- A431 cells in vitro and xenograft tumors in animals
- Limits stated in the abstract
- The abstract describes only preclinical cell and animal experiments, with a confidence interval for the hazard ratio that includes 1 and no human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Angiogenesis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.